AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally
GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment
Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided'
Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug